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AbstrAct
Introduction: Decreased heart rate varia-
bility (HRV) in patients with end stage 
renal disease (ESRD) undergoing hemo-
dialysis is predictive of cardiac death, es-
pecially due to sudden death. Objective: 
To evaluate the effects of aerobic training 
during hemodialysis on HRV and left 
ventricular function in ESRD patients. 
Methods: Twenty two patients were ran-
domized into two groups: exercise (n = 
11; 49.6 ± 10.6 years; 4 men) and con-
trol (n = 11; 43.5 ± 12.8; 4 men). Patients 
assigned to the exercise group were sub-
mitted to aerobic training, performed du-
ring the first two hours of hemodialysis, 
three times weekly, for 12 weeks. HRV 
and left ventricular function were asses-
sed by 24 hours Holter monitoring and 
echocardiography, respectively. Results: 
After 12 weeks of protocol, no significant 
differences were observed in time and fre-
quency domains measures of HRV in bo-
th groups. The ejection fraction improved 
non-significantly in exercise group (67.5 
± 12.6% vs. 70.4 ± 12%) and decreased 
non-significantly in control group (73.6 
± 8.4% vs. 71.4 ± 7.6%). Conclusion: A 
12-week aerobic training program perfor-
med during hemodialysis did not modify 
HRV and did not significantly improve 
the left ventricular function.
Keywords: exercise, renal dialysis, heart 
rate, ventricular function, left.
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IntroductIon
The high mortality rate among patients 
with chronic kidney disease (CKD) under-
going hemodialysis is mainly associated 
with a high prevalence of cardiovascular 
diseases, such as coronary artery disea-
se, arterial hypertension, left ventricular 
hypertrophy, and heart failure.1 Another 
relevant cardiovascular event in those pa-
tients is the occurrence of cardiac arrhyth-
mias, which represent the major cause of 
sudden death.2
The development of cardiac arrhyth-
mias in patients with CKD is associated 
with autonomic dysfunction evidenced 
by the reduction in heart rate variability 
(HRV).3 In addition, the reduction in HRV 
represents an independent risk factor for 
cardiac mortality in those patients.4,5
Thus, strategies, such as exercise trai-
ning, have been implemented aiming at re-
ducing cardiovascular mortality due to an 
increase in HRV and improvement of the 
left ventricular function, specially in the 
population with heart disease.6,7 However, 
only a few studies have assessed the effect 
of an exercise training program on those 
cardiovascular parameters in patients wi-
th CKD undergoing hemodialysis.8-11
This study aimed at assessing the 
effects of guided aerobic training during 
hemodialysis sessions on HRV and left 
ventricular function of patients with CKD.
Methods
Patients
The sample comprised patients wi-
th CKD undergoing hemodialysis at 
the Nephrology Service of the Hospital 
Universitário of the Universidade Federal 
de Juiz de Fora, state of Minas Gerais, 
three times a week, in a total of 12 hours 
per week, for at least six months. During 
hemodialysis sessions, polysulfone mem-
brane and bath with the following cha-
racteristics were used: sodium, 138.0 
mEq/L; potassium, 2.0 mEq/L; calcium, 
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2.5 mEq/L; magnesium, 1.0 mEq/L; chloride, 108.5 
mEq/L; acetate, 3.0 mEq/L; bicarbonate, 32.0 
mEq/L. Adult patients, of both sexes, who did not 
exercise on a regular basis for at least six months 
were included. 
The exclusion criteria were as follows: diabe-
tes mellitus; unstable angina; uncontrolled arterial 
hypertension [systolic blood pressure (SBP) ≥ 200 
mm Hg and/or diastolic blood pressure (DBP) ≥ 
120 mm Hg]; use of antiarrhythmic drugs; severe 
pneumopathies; acute systemic infection; severe re-
nal osteodystrophy; and disabling neurological and 
muscle-skeletal disorders. 
The study project was approved by the Committee 
on Ethics in Research of the Universidade Federal de 
Juiz de Fora and all patients who agreed to partici-
pate in the study provided written informed consent.
 
exPerimental PrOcedure
Initially, the patients included in the study were rando-
mized into an exercise and a control group. Patients in 
the exercise group underwent three sessions of aero-
bic exercise per week, performed during hemodialysis 
sessions, for 12 weeks, while patients in the control 
group remained in the usual dialytic treatment.
At baseline and after 12 weeks in the study, all 
patients underwent Holter monitoring and echo-
cardiography, conducted by examiners who did not 
know about the groups. In addition, a blood sample 
was also collected.
 
HOlter mOnitOring and Heart rate variability as-
sessment 
Holter monitoring was performed for 24 hours, in the 
interdialytic period, by use of a digital Holter monitor 
(DMS 300-7, Compact Flash Card Holter Recorder, 
DMS, Nevada, USA). The data stored were processed 
by use of the Cardio Scan 8.0 software to assess HRV. 
Abnormal beats and artifact areas were automatically 
and manually identified and excluded from analysis. 
Heart rate variability was assessed in the time and fre-
quency domains.
For analysis in the time domain, normal R-R in-
tervals were called iNN. To assess HRV in the time 
domain and based on iNN, the following parameters 
were obtained by use of statistical methods: mean of 
the standard deviations of iNN every five minutes 
(SDNN index); root of the mean squared difference 
of successive iNN (RMSSD); and percentage of suc-
cessive iNN with a difference in duration greater than 
50 ms (pNN50).12
When assessing HRV in the frequency domain, 
a low frequency (LF) band (between 0.04 and 0.15 
Hz) and a high frequency (HF) band (between 0.15 
and 0.40 Hz) were used. The LF/HF ratio was 
obtained.12
Beta-blockers were suspended four days before 
Holter monitoring. 
ecHOcardiOgraPHy
M mode and two-dimensional echocardiography 
was performed in the interdialytic period by a sin-
gle cardiologist, with the Doppler technique (VIVID 
3 - GE Healthcare, Milwaukee, Wisconsin, USA). 
Anatomical and functional data were obtained at 
rest by use of a 3.5-MHz linear transducer, placed on 
the third or fourth left intercostal space. Measures 
were obtained and analyzed according to the guide-
lines of the American Society of Echocardiography.13
Left ventricular mass index was obtained by cor-
recting left ventricular mass to body surface.14,15 The 
geometrical classification of the left ventricle was 
based on the assessment of left ventricular mass and 
relative wall thickness.15 The following indices were 
measured for assessing left ventricular function: end 
diastolic volume; end systolic volume; systolic volu-
me; and ejection fraction.
 
labOratOry data
The following values were assessed: hemoglobin (g/
dL); hemodialysis efficiency index (Kt/V); creatinine 
(mg/dL); phosphorus (mg/dL); potassium (mEq/L); 
calcium (mg/dL); and albumin (g/dL). Blood samples 
were collected before the hemodialysis session, with 
no indication of fasting. 
 
aerObic exercise
Supervised aerobic training was performed within 
the first two hours of hemodialysis, and lasted, on 
average, one hour. The training comprised three 
steps: warm up; conditioning; and cool down. A hori-
zontal electromagnetic cycle ergometer (Movement, 
BM 4000, Brudden Equipamentos Ltda, São Paulo, 
Brazil) was used for aerobic exercise training.
Warm up comprised stretching the lower limbs 
for approximately 10 minutes, and aerobic exercise 
training with low load (4.9 N.m) and at low rotation 
(up to 35 rpm) for five minutes. Conditioning con-
sisted of aerobic exercise training for up to 35 minu-
tes. The duration of exercise training was individua-
lized according to the response of the patients: they 
started training for a period of time with which they 
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felt comfortable and were encouraged to increase the 
length of training session to complete 35 minutes. 
Load was assigned according to the tolerance of ea-
ch patient, who was instructed to maintain a cons-
tant rotation throughout the entire aerobic exercise 
training. The intensity of the training was determi-
ned by the Borg-modified scale, in which patients 
had to remain between four and six.16 Cool down 
consisted in one to three minutes of aerobic exercise 
with a 4.9 N.m load and at low rotation.
Arterial blood pressure was monitored at rest, 
every five minutes during conditioning, and after 
cool down. Heart rate was continuously monitored 
by use of a cardiofrequencemetre (Polar F1, Polar 
Electro Oy, Kempele, Finland). 
The criteria for interrupting aerobic exercise in-
cluded intense physical fatigue, chest pain, dizziness, 
paleness, lipothymia, tachycardia, hypotension, and 
lower limb fatigue. 
When patients had a change in blood pressure 
(SBP > 180 mm Hg and/or DBP > 110 mm Hg), in-
terdialytic weight gain greater than 5 kg, difficulty 
in vascular access, or any significant complain (pain, 
dyspnea) before exercise training, they could not 
exercise on that day or while such changes persisted. 
 
statistical analysis
Data were expressed as mean ± standard deviation 
or median (interquartile range), when appropriate. 
For comparing initial and final values in each group, 
paired t test and Wilcoxon test were used for pa-
rametric and nonparametric data, respectively. For 
comparing the groups, non-paired t test or Mann-
Whitney test were used, when appropriate. 
Difference was considered statistically significant 
when p value was lower than 0.05. All analyses were 
performed in the SPSS 13.0 for Windows program 
(SPSS Inc, Chicago, USA).
 
results
cHaracteristics Of tHe Patients
Of the 81 patients on chronic hemodialysis, 28 met 
the inclusion criteria and agreed to participate in the 
study. Of those, 22 patients completed the study, 11 
in each group (Figure 1). As shown in Table 1, no 
significant difference was observed in the clinical 
and demographic characteristics and medications 
between the groups assessed.
After 12 weeks following the protocol, a signi-
ficant difference was observed in neither dry wei-
ght (exercise group: 59 ± 4.6 kg vs. 59.1 ± 4.4 kg; 
control group 59.7 ± 15.3 kg vs. 59.6 ± 15.4 kg) nor 
interdialytic weight gain (exercise group: 1.9 ± 0.8 
kg vs. 2.2 ± 0.9 kg; control group 1.7 ± 0.6 kg vs. 
1.6 ± 0.8 kg). Similarly, the anti-hypertensive dru-
gs and phosphorus binders were maintained in both 
groups.
aerObic exercise
Adherence to exercise training during the 12 we-
eks was 75.3 ± 15.2%, and no significant clinical 
complication was observed during training. The 
major causes for skipping training were report of 
pain and fatigue, in addition to pre-dialysis arterial 
hypotension. 
 
Heart rate variability
After 12 weeks following the protocol, no signifi-
cant difference was observed in the HRV parameters 
in the time and frequency domains in both groups 
(Table 2).
ecHOcardiOgraPHic data
At baseline and at the end of 12 weeks of training, 
no significant difference was observed in the echo-
cardiographic variables between the exercise and 
control groups. Most patients had concentric left 
ventricular hypertrophy (seven in the exercise group 
and eight in the control group), while concentric re-
modeling was identified in the others.
Figure 1. Flowchart of patients throughout the protocol.
Patients on 
hemodialysis (n=81)
Randomized (n=28)
Control group (n=14)Exercise group (n=14)
Final assessment (n=11) Final assessment (n=11)
Final assessment (n=11)
Cause:
– Lack of adherence to 
the protocol (n=3)
Excluded (n=3)
Cause:
– Coronary artery 
disease (n=2)
– Lack of adherence to 
the protocol (n=1)
Excluded (n=53)
Cause:
– Did not meet the 
inclusion criteria (n=41)
– Did not agree to 
participate in the study 
(n=12)
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Characteristics Exercise group (n = 11) Control group (n = 11) p
Age (years) 49.6 ± 10.6 43.5 ± 12.8 0.23
Sex (men/women) 4/7 4/7
Dialysis time (months) 41.9 ± 42.4 60.1 ± 54.4 0.39
Dry weight (kg) 59 ± 4.6 59.7 ± 15.3 0.88
BMI (kg/m2) 22.6 ± 2.3 22.9 ± 4.1 0.82
Etiology of CKD (patients, %):
   Chronic glomerulonephritis 5 (45.5%) 7 (63.6%)
   Arterial hypertension 2 (18.2%) 1 (9.1%)
   Renal amyloidosis 2 (18.2%) 0
   Hemolytic uremic syndrome 1 (9.1%) 0
   Obstructive uropathy 0 1 (9.1%)
   Systemic lupus erythematosus 0 2 (18.2%)
   Undefined 1 (9.1%) 0
Anti-hypertensive drugs (patients, %):
   Calcium channel blockers 6 (54.5%) 5 (45.5%)
   Beta-blockers 5 (45.5%) 4 (36.4%)
   ACEI 6 (54.5%)  4 (36.4%)
   Central action blockers 2 (18.2%) 3 (27.3%)
   Diuretics 4 (36.4%) 3 (27.3%)
   AT1 receptor blocker 1 (9.1%) 3 (27.3%)
Phosphorus binders 
   Calcium acetate 7 (63.6%) 7 (63.6%)
   Calcium carbonate 3 (27.3%) 1 (9.1%)
   Sevelamer 1 (9.1%) 3 (27.3%)
BMI: body mass index; CKD: chronic kidney disease; ACEI: angiotensin-converting enzyme inhibitors
Table 1 clinical and demOgraPHic cHaracteristics Of tHe exercise and cOntrOl grOuPs
Table 2 Parameters Of Heart rate variability in tHe time and frequency dOmains at baseline and end Of  
 12 weeks in tHe exercise and cOntrOl grOuPs
Exercise group (n = 11) Control group (n = 11)
Baseline Week 12 Baseline Week 12
Time Domain
SDNN index (ms) 34.6 ± 10.6 32.6 ± 9.7 39.1 ± 10.2 40.4 ± 12.7 
RMSSD (ms) 19.9 ± 10.1 21.4 ± 9.7 22.6 ± 8 24 ± 6.9 
pNN50 (%) 1 (3) 1 (8) 2 (6) 4 (7)
Frequency domain
LF (ms2) 297.3 ± 163.7 302.1 ± 191.5 328.3 ± 139.6 416.7 ± 305.8
HF (ms2) 73.7 (87.9) 81.4 (58.3) 118.1 (66.8) 108.2 (90.1)
LF/HF 3.7 (1.1) 4 (3.4) 3.2 (2.3) 3.3 (2.1)
Values expressed as mean ± standard deviation or median (interquartile range).   LF: low frequency; HF: high frequency.
After the aerobic training period, no echocar-
diographic parameter showed a significant increase 
(Table 3). The ejection fraction increased in seven of 
the 11 patients of the exercise group and decreased in 
most patients of the control group (Figure 2).
labOratOry data 
After 12 weeks following the protocol, a significant 
increase in potassium was observed in both groups, 
and in creatinine and albumin in the control group 
(Table 4).
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Table 3 variables Obtained On ecHOcardiOgraPHy at baseline and end Of 12 weeks in tHe exercise and  
 cOntrOl grOuPs
Exercise group (n = 11) Control group (n = 11)
Baseline Week 12 Baseline Week 12
LVMI (g/m2) 118.7 ± 25.7 120.9 ± 26.6 132.6 ± 49.1 131.3 ± 48.4
EDV (mL) 113 ± 50.7 133 ± 31.1 116.6 ± 36.5 117 ± 40.5 
ESV (mL) 42.2 ± 29.3 44.6 ± 27.1 32.4 ± 20.4 35 ± 18.4 
EF (%) 67.5 ± 12.6 70.4 ± 12 73.6 ± 8.4 71.4 ± 7.6 
SV (mL) 74.9 ± 24.4 88.8 ± 15.8 84.2 ± 20.6 82 ± 27.1 
Values expressed as mean ± standard deviation.   LVMI: left ventricular mass index; EDV: end-diastolic volume; ESV: end-systolic 
volume; EF: ejection fraction; SV: systolic volume.
dIscussIon
The present study showed that 12 weeks of super-
vised aerobic training during hemodialysis sessions 
neither modified HRV nor significantly improved left 
ventricular function. 
The HRV analysis is a non-invasive investigative 
method to assess the autonomic modulation exerted 
on the sinus node and has been described as one of the 
Table 4 labOratOry findings at baseline and end Of 12 weeks in tHe exercise and cOntrOl grOuPs
Control group (n = 11) Control group (n = 11)
Baseline Week 12 Baseline Week 12
Hemoglobin (g/dL) 10.6 ± 2.9 10.9 ± 2.8 11.4 ± 2 11.3 ± 2.6
Kt/V 1.6 ± 0.2 2.0 ± 0.8 1.6 ± 0.3 1.8 ± 0.7
Creatinine (mg/dL) 11.9 (4.3) 12.6 (4.7) 9.3 (3) 10.5 (3.3)*
Phosphorus (mg/dL) 5.5 ± 2.1 4.9 ± 1.7 6.3 ± 1.2 5.9 ± 1.9
Potassium (mEq/L) 4.5 (0.6) 5.3 (1)* 4.7 (0.9) 5.2 (2)*
Calcium (mg/dL) 9.8 (1.2) 9.8 (1.6) 10 (1.4) 10.2 (1)
Albumin (g/dL) 3.9 ± 0.3 3.9 ± 0.3 3.9 ± 0.4 4.1 ± 0.5*
Values expressed as mean ± standard deviation or median (interquartile range).  *p < 0.05, baseline; Kt/V: hemodialysis efficiency 
index.
most sensitive techniques for diagnosing autonomic 
dysfunction.3,12,17,18 The HRV reduction in patients 
with CKD is considered a risk factor for the occur-
rence of  cardiac arrhythmias, and is associated with 
a higher cardiovascular mortality.4,5 Cashion et al.19, 
assessing hemodialysis patients by use of 24-hour 
Holter to study HRV in the time and frequency do-
mains for a period of two years, have reported that 
the reduction in the SDNN, LF, and LF/HF parame-
ters predicted cardiovascular death, especially sudden 
death. In that population, the reduction in HRV asso-
ciated with injury to the parasympathetic system due 
to the structural impairment of arteries or the func-
tional alterations of the autonomic nervous system 
secondary to uremic toxins.18-20
The increase in HRV in patients with CKD has 
been observed with kidney transplantation and the 
practice of exercise programs.10,11,21,22 The present 
study did not show an increase in the HRV assessed 
in the time and frequency domains after 12 weeks 
of aerobic training. That finding is likely to be asso-
ciated with the exercise training period. Contrarily, 
Deligiannis et al.10, submitting 30 patients with CKD 
undergoing hemodialysis to 24 weeks of exercise 
Figure 2. Individual data of ejection fraction obtained 
on echocardiography at baseline and end of the 12 
weeks in the exercise and control groups. 
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during the interdialytic period, have reported a signi-
ficant increase in HRV assessed on 24-hour Holter. In 
another study, those same authors applied 40 weeks 
of aerobic exercise and strength training during hemo-
dialysis sessions and have also reported an improve-
ment in HRV.11 However, the training time seems to re-
late to an improvement in HRV in patients with CKD.
The choice of the 12-week training period of this 
study was due to the benefits observed in previous 
protocols developed in our center. One of such stu-
dies has assessed the effect of a 12-week intradialytic 
aerobic training in 14 patients with CKD. After the 
training period, the following was observed: a reduc-
tion in blood pressure assessed by use of 24-hour am-
bulatory blood pressure monitoring; improvement in 
the quality of life assessed by use of the SF-36 ques-
tionnaire; an increase in functional capacity assessed 
by use of the six-minute walking test; and improve-
ment of anemia and Kt/V23. The present study has not 
shown a significant increase in hemoglobin and Kt/V 
after 12 weeks of aerobic training. The significant in-
crease in potassium in both groups and in creatinine 
and albumin in the control group was not clinically 
relevant. 
In addition to HRV, left ventricular function has 
also been assessed by use of resting echocardiography. 
Although no significant improvement has been obser-
ved in the ejection fraction after the training period, 
that parameter increased in seven of the 11 patients 
in the exercise group. The duration of training also 
seems to have influenced the improvement in left ven-
tricular function. In accordance, Shalom et al.8 have 
reported that 12 weeks of exercise training were not 
accompanied by a significant improvement in left 
ventricular function. On the other hand, other pro-
tocols with longer training have shown a significant 
increase in ejection fraction.9,11 In one of such studies, 
the authors have assessed left ventricular function by 
use of resting and stress echocardiography of 16 he-
modialysis patients with CKD undergoing a 24-week 
aerobic and strength training in the interdialytic pe-
riod. After the training period, significant gains in the 
ejection fraction and systolic volume were observed 
on resting echocardiography; however, on stress echo-
cardiography, significant increases were observed in 
the ejection fraction, systolic volume, and cardiac ou-
tput.9 That result has also been confirmed after 40 
weeks of aerobic and strength training during hemo-
dialysis sessions.11
The aerobic training applied during hemodialy-
sis sessions for 12 weeks in this study did not cau-
se a significant improvement in the cardiovascular 
parameters assessed. Patients with CKD undergoing 
an exercise program have shown central adaptations, 
such as improvement of the cardiac performance, and 
mainly an improvement in peripheral mechanisms, re-
presented by strength and muscle resistance gains, in 
addition to neural adjustments evidenced by an incre-
ase in the nervous conduction velocity.24,25 Those data 
have been recently confirmed in a study developed by 
our group, in which, after 12 weeks of intradialytic 
aerobic training, a significant increase was observed 
in the kinetics of oxygen consumption.26 Thus, our 
data allow the speculation that the time of training 
used in the present study provided an improvement 
in peripheral mechanisms, although consistent be-
nefits regarding central mechanisms have not been 
observed. The discrepancy between our findings and 
those in the literature allows suggesting that aerobic 
exercises for patients with CKD aiming at assessing 
HRV should be prescribed for periods longer than 12 
weeks.
 
conclusIon
Twelve weeks of supervised aerobic training during 
hemodialysis sessions have not modified HRV and 
have not promoted a significant improvement of left 
ventricular function. New protocols with longer trai-
ning periods are required for assessing the effects of 
aerobic exercise in those cardiovascular parameters.
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